about
Adverse effects of pefloxacin in irradiated C3H/HeN mice: correction with glucan therapyPersistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever.Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infections with Listeria monocytogenes in hydrocortisone-treated mice.Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureusInfluence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages.Mechanisms of fluoroquinolone transport by human neutrophils.Fluoroquinolone transport by human monocytes: characterization and comparison to other cells of myeloid lineage.Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrationsEfficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophagesActive efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter.Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1Oral ciprofloxacin treatment for Salmonella typhimurium infection of normal and immunocompromised mice.Treatment of experimental Salmonella typhimurium infection in mice with fleroxacinEffect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophilaLiposome-incorporated ciprofloxacin in treatment of murine salmonellosis.The crucial role of polymorphonuclear leukocytes in resistance to Salmonella dublin infections in genetically susceptible and resistant mice.Lack of effective bactericidal activity of new quinolones against Brucella spp.Evaluation of enrofloxacin use in koalas (Phascolarctos cinereus) via population pharmacokinetics and Monte Carlo simulation.Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions.Effects of enrofloxacin on porcine phagocytic function.Mechanism of therapeutic effectiveness of cefixime against typhoid fever.Novel poly-DL-lactide-polycaprolactone copolymer based flexible drug delivery system for sustained release of ciprofloxacin.Discrepancy between uptake and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic cell modelUptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells.Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes.Mechanisms that may account for differential antibiotic susceptibilities among Coxiella burnetii isolates.Salmonella Osteomyelitis.Bordetella bronchiseptica pneumonia in a patient with AIDS.Determination of intracellular concentrations of free and two types of liposome-encapsulated enrofloxacin in anatolian shepherd dog monocytes.Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs.Successful treatment of vaginal malakoplakia in a young cat.
P2860
Q24679877-0F59C9EE-65DE-49C9-BFD2-2EFB235030B1Q31140106-F3C59159-239D-4DB9-ADCD-FB43CB9DAE2DQ33744795-04EB3E92-02AC-406E-879D-850AB42E573DQ33745800-96311DA5-80BD-4121-A8C8-BEDCB4155B31Q33836590-4F2671E0-65CC-417E-B9DF-4D6B84489501Q33978050-E39BDB87-DB44-409A-8EEA-B91C0CEB88FEQ33980670-F6B0CCE6-EB38-44E7-BABE-7D4F4271335EQ34109849-2C4E4931-7A10-4098-A2BE-5E80D7486F73Q34534012-E94BF561-7756-4631-AD52-6571B07E85C8Q35102754-A613B040-AADD-4A1E-BD0E-76CA9A982EBFQ35125010-B4C3F0F9-E109-4F7A-9453-DA53E885FD2FQ35272717-51919DDC-ABAC-4B33-83A9-781FE38AECBAQ35288542-80FA7DA1-9AFE-4555-9021-E1C0F7E3E406Q35307223-7466959E-D948-49D5-A09C-F4CFA2F3B434Q35542379-EF686EDD-5EEB-4F5D-B405-6C255C29A6CFQ35899686-DD65817F-2B15-4475-B84B-371877B116ABQ36505591-87D9BE77-2CB1-4635-80BA-C85E32DE7D62Q36753441-FDA2052D-B93A-4BB1-BA6F-25D7DD90494DQ37845550-8FCEBA59-F53F-4590-B314-B60148ABCB9CQ39214819-27E635AC-916C-4485-97BB-FA8E983878F2Q39471666-202BC4B8-B009-4F8D-8F19-76E4D99E02B8Q39478164-EE55F3AE-D282-4521-9E3B-019231FF4645Q39614940-87F4B64C-5A8A-4754-AEE6-1CE949F8C9D0Q39651212-C6E42D38-D905-435F-8566-6C654CE26AACQ39815370-6E8918A6-4239-4F41-AEAE-BAD15B6021AAQ39819180-07284D5C-8562-4536-B137-F8459E113BA3Q40086579-7B0D1122-54A7-42A4-9C86-1E81AA1D3E3BQ40127050-E20E5329-FD86-4512-91D8-62D3163F5223Q41233252-75C50CE7-3CDA-4842-9647-EDE7E5CB4CB6Q44144777-69A6930A-FA39-4B11-958D-9A828C935AE8Q44869380-1DAF6C23-BD67-4703-8259-5440900F54E6Q53301206-7200FA35-2B3A-4F3B-9A8B-283DC3000BBA
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Uptake of ciprofloxacin by macrophages
@en
Uptake of ciprofloxacin by macrophages.
@nl
type
label
Uptake of ciprofloxacin by macrophages
@en
Uptake of ciprofloxacin by macrophages.
@nl
prefLabel
Uptake of ciprofloxacin by macrophages
@en
Uptake of ciprofloxacin by macrophages.
@nl
P2860
P356
P1476
Uptake of ciprofloxacin by macrophages
@en
P2093
P2860
P304
P356
10.1136/JCP.38.4.442
P407
P577
1985-04-01T00:00:00Z